Work

Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial – Authors' reply

Year: 2024

Type: letter

Source: The Lancet

DOI: 10.1016/s0140-6736(24)00801-8

Authors: Pierce K H Chow, Stephen P Hack, Jessica H Spahn, Adam C Yopp

Institutions: National University of Singapore, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore, Genentech, The University of Texas Southwestern Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Roche

OpenAlex ID: W4401598868

Cites: 7

Cited by: 1

Related to: 10